UK okays Alexion drug costing up to $2 mln but wants price cut

LONDON, Sept 22 (Reuters) - A new drug to treat a rare

inherited bone disorder that was developed by Alexion

Pharmaceuticals and could cost up to 1.5 million pounds

($2 million) a year per patient...

Read more